XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 26.66

+2.0%

12:36 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Cacaito who wrote (9701)	4/29/1999 1:24:00 PM
From: aknahow	Read Replies (1) of 17367

Description in detail of a different clinical trial for meningococcal sepsis. NOTE the reference to 30% mortality for patients with glasgow of 8 or above! Does not mean it is not lower in the U.K. but supports what you have said many times. "The inclusion criteria for the patients should be SAPF with a Glasgow meningoccocal septicaemia prognostic score of 8 or >8 which predicts a mortality of about 30 % or more." kfunigraz.ac.at One more day at the BARGA meeting in Italy.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next